Conflict of interest register and management

From Cancer Guidelines Wiki

Working Party Members were asked to declare in writing, any interests relevant to the guideline development, prior to commencement. Members were asked to update their information if they became aware of any changes to their interests. All declarations were added to a register of interests as listed below.

If Working Party Members were identified as having a significant real or perceived conflict of interest, the Chair could decide that the member either leave the discussion whilst the specific area they were conflicted in was discussed or the member could remain present but not participate in the discussion, or decision making on the specific area where they were conflicted. There were no instances where this occurred during the development of this guideline.

The guidelines have now entered the updating phase. Guideline working party members are responsible to update their conflict of interest statements if a new interest arises. The members will receive a formal reminder to review their statements and ensure it is up-to-date prior to the yearly meetings that will be scheduled to review all updates.

Conflict of interest register

Working party members

Author Conflict of interest declaration
Dr Alison Brand (Chair)

Gynaecological Oncologist – Westmead Hospital, Sydney NSW

No conflict of interest to declare
Professor Ian Hammond (Deputy Chair)

Gynaecological Oncologist, Cancer Australia Advisory Group/ King Edward Memorial Hospital, Perth WA

No conflict of interest to declare
Dr Robyn Cheuk

Radiation Oncologist, Cancer Australia Advisory Group/ Royal Brisbane and Womens Hospital, Brisbane QLD

No conflict of interest to declare
Kathryn Crisell

Gynaecological cancer consumer, Adelaide SA

No conflict of interest to declare
Assoc Professor Margaret Davy

Gynaecological Oncologist, Cancer Australia Advisory Group/ Royal Adelaide Hospital, Adelaide SA

Has been a member of the GSK Advisory Board for Cervarix and also given lectures sponsored by GSK and CSL
Dr Andrew Dean

Medical Oncologist, St John of God Hospital, Perth WA

Has been on an Advisory Board for Specialised Therapeutics Australia and received an honorarium from them
Dr Louise Farrell

Gynaecologist, King Edward Memorial Hospital, Perth WA

Has received sponsorship to attend meetings from GSK, MSD and CSL. Has received a grant from GSK to run a survey of Gynaecologists’ attitude to HPV vaccines. Is an investigator in both CSL and GSK HPV vaccine trials
Jane Francis

Manager, Gynaecological Cancers, Cancer Australia

No conflict of interest to declare
Clinical Associate Professor Russell Hogg

Gynaecological Oncologist, Westmead Hospital, Sydney NSW

No conflict of interest to declare
Lesley McQuire

Gynaecological cancer consumer, Sydney NSW

No conflict of interest to declare
Dr Selvan Pather

Gynaecological Oncologist, Royal Prince Alfred Hospital, Sydney NSW

No conflict of interest to declare
Dr Frances Quirk

Sexologist, Townsville QLD

No conflict of interest to declare
Dr Felicity Rea

General Practitioner, Toowoomba QLD

No conflict of interest to declare
Dr Colin Stewart

Histopathologist, WA

No conflict of interest to declare
Ella Curnow

Project Officer - Cancer Australia

No conflict of interest to declare
Professor Ian Olver AM (Convenor)

CEO - Cancer Council Australia

No conflict of interest to declare
Christine Vuletich

Manager - Clinical Guidelines Network, Cancer Council Australia

No conflict of interest to declare
Alice Winter-Irving

Project Officer - Clinical Guidelines Network, Cancer Council Australia

No conflict of interest to declare
Jutta von Dincklage

Project Manager - Wiki Development, Cancer Council Australia

No conflict of interest to declare

Contributing authors

Author Conflict of interest declaration
Dr Linda Mileshkin

Medical Oncologist, Peter MacCallum Cancer Centre

Melbourne VIC

Australian PI for ANZGOG international PORTEC 3 trial. Hospira is supplying paclitaxel for Australian patients in this trial.
Dr Marcelo C Nascimento

Gynaecological Oncologist, Mater Hospital and Gold Coast Hospital, QLD

No conflict of interest to declare
Professor Andreas ObermairGynaecological Oncologist, Queensland Centre for Gynaecological Cancer, The University of Queensland, Brisbane QLD Has received sponsorship to attend conferences from Gate Health who market the McCartney tube
Dr Kym Reid

Gynaecological Oncology Fellow, Brisbane QLD

No conflict of interest to declare
Dr Colin Stewart

Histopathologist, St John of God Pathology, Perth WA

No conflict of interest to declare
Ai Ling Tan

Gynaecological Oncologist

Auckland, New Zealand 

Involved in a trial as an investigator sponsored by GSK

Prevalance of HPV16,18 in cervical cancer in NZ women